Skip to main content
Caplight Logo









Kincell Bio

Kincell Bio

Private
Gainesville, FloridaHealthcare & Life Scienceshttps://kincellbio.com/

Last Round

VC Round

May 15, 2025

Total Funding Raised

$36M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Kincell Bio is a biotechnology company that provides contract development and manufacturing organization (CDMO) services for immune cell therapies.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Clinical Trials, Pharma Supply Chain, Quality Management

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Application

Keywords

CDMOcell therapy manufacturinggene therapy manufacturingcontract developmentGMP manufacturingchemistry, manufacturing, and controlsCMCprocess developmentanalytical developmentbiotech manufacturingclinical supplybioprocessingcommercial scale productioncell therapy scale-upbiotech outsourcing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Kincell Bio Comparables

Compare Kincell Bio with similar companies based on industry and business-model similarity.

Kincell Bio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
eXmoor Pharma
84%
RoslinCT
81%
OrganaBio
80%

Kincell Bio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundMay 15, 2025
Series AJul 26, 2023

Key People

Founding team and executive leadership

Larry Pitcher

Chief Executive Officer

Executive Team

Bruce Thompson

Chief Technology Officer

Executive Team

Kincell Bio Investors

Notable investors and investment history

Kincell Bio investors
InvestorRounds
NewSpring CapitalVC Round
Kineticos VenturesSeries A, VC Round

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 27, 2026

    Monthly visitors increased 72% MoM.

  • Apr 14, 2026

    Expanded operations in Research Triangle Park, North Carolina.

Kincell Bio Filings

Explore SEC and related filing metadata, where available.

Kincell Bio filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Kincell Bio's valuation, stock price, and market status.

Is Kincell Bio a public or private company?

Kincell Bio is a private company.

What is the current stock price of Kincell Bio?

Kincell Bio is a private company with no public stock price. No recent secondary market data is available.

How much is Kincell Bio worth (valuation)?

Valuation information for Kincell Bio is not publicly available.

Can I buy Kincell Bio stock?

Kincell Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Kincell Bio's last funding round?

Kincell Bio's most recent funding round was Early Funding on May 15, 2025.

Who are the main investors in Kincell Bio?

Key investors in Kincell Bio include NewSpring Capital, Kineticos Ventures.

Will Kincell Bio IPO soon?

No public IPO plans have been announced for Kincell Bio.

How can I track Kincell Bio secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Kincell Bio's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersGainesville, Florida
Employee Range81
Year Founded2023
Last FundingMay 15, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?